T2 Biosystems, Inc
TTOO
TTOO was delisted on the 11th of February, 2025.
63 hedge funds and large institutions have $28.6M invested in T2 Biosystems, Inc in 2019 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 15 increasing their positions, 13 reducing their positions, and 20 closing their positions.
52% more call options, than puts
Call options by funds: $260K | Put options by funds: $171K
15% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 13
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
11% less funds holding
Funds holding: 71 → 63 (-8)
25% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 20
47% less capital invested
Capital invested by funds: $53.8M → $28.6M (-$25.3M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$1.69M |
| 2 |
Millennium Management
New York
|
+$1.48M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$551K |
| 4 |
Jane Street
New York
|
+$445K |
| 5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$328K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Senvest Management
New York
|
-$3.91M |
| 2 |
BlackRock
New York
|
-$3.4M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$1.05M |
| 4 |
State Street
Boston,
Massachusetts
|
-$925K |
| 5 |
BRC
Bell Rock Capital
Rehoboth Beach,
Delaware
|
-$897K |
TTOO Hedge Fund Activity: Q2 2019 in Review
63 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q2 2019, worth a combined $28.6M — down 47% from $53.8M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of TTOO and 15 opened new positions — a net loss of 5 holders — while 13 trimmed existing stakes and 15 added.
The largest buyer was JP Morgan Chase, adding an estimated $1.69M. The largest seller was Senvest Management, cutting an estimated $3.91M.
- 63 institutional investors held T2 Biosystems, Inc (TTOO) as of Q2 2019, down from 71 in Q1 2019.
- Funds reported $28.6M of T2 Biosystems, Inc stock for Q2 2019, down 47% quarter-over-quarter.
- 15 funds opened new T2 Biosystems, Inc positions in Q2 2019 and 20 closed out, a net change of -5 holders.
- The largest T2 Biosystems, Inc buyer in Q2 2019 was JP Morgan Chase, an estimated $1.69M added.
- The largest T2 Biosystems, Inc seller in Q2 2019 was Senvest Management, an estimated $3.91M sold.
Based on aggregated 13F filings for Q2 2019.